Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Brookfield
BN
$109B
| $6.34M | ﹤0.01% |
230,796
+2,543
| +1% | +$65.1K |
|
2227
Usana Health Sciences
USNA
$254M
| $6.32M | ﹤0.01% |
61,708
-2,673
| -4% | -$268K |
|
2228
FB Financial Corp
FBK
$3.1B
| $6.3M | ﹤0.01% |
168,848
+10,649
| +7% | +$442K |
|
2229
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.44B
| $6.3M | ﹤0.01% |
75,317
+2,354
| +3% | +$188K |
|
2230
Emergent Biosolutions
EBS
$241M
| $6.29M | ﹤0.01% |
99,818
+8,159
| +9% | +$524K |
|
2231
KVH Industries
KVHI
$144M
| $6.28M | ﹤0.01% |
510,201
-74,200
| -13% | -$1M |
|
2232
Henry Schein
HSIC
$9.99B
| $6.25M | ﹤0.01% |
84,268
-8,124
| -9% | -$612K |
|
2233
TTM Technologies
TTMI
$14.9B
| $6.25M | ﹤0.01% |
437,112
-305,144
| -41% | -$4.56M |
|
2234
St. Joe Company
JOE
$3.91B
| $6.24M | ﹤0.01% |
139,951
-1,627
| -1% | -$73.4K |
|
2235
Cytokinetics
CYTK
$10.4B
| $6.24M | ﹤0.01% |
315,022
-1,007
| -0.3% | -$23.6K |
|
2236
WisdomTree
WT
$3.39B
| $6.22M | ﹤0.01% |
1,003,888
+111,723
| +13% | +$737K |
|
|
UNVR
2237
DELISTED
Univar Solutions Inc.
UNVR
| $6.22M | ﹤0.01% |
255,221
-14,373
| -5% | -$360K |
|
2238
Ambarella
AMBA
$3.63B
| $6.22M | ﹤0.01% |
58,335
-3,397
| -6% | -$336K |
|
|
CYBE
2239
DELISTED
Cyberoptics Corp
CYBE
| $6.21M | ﹤0.01% |
+151,680
| New | +$4.71M |
|
2240
Safety Insurance
SAFT
$1.52B
| $6.21M | ﹤0.01% |
79,270
+14,331
| +22% | +$1.2M |
|
2241
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$162M
| $6.19M | ﹤0.01% |
180,762
+6,646
| +4% | +$222K |
|
2242
indie Semiconductor
INDI
$832M
| $6.18M | ﹤0.01% |
+625,400
| New | +$5.96M |
|
2243
Xerox
XRX
$410M
| $6.17M | ﹤0.01% |
262,277
-175,919
| -40% | -$4.25M |
|
2244
Applied Optoelectronics
AAOI
$11.7B
| $6.14M | ﹤0.01% |
724,427
+612,548
| +548% | +$4.99M |
|
2245
Nu Skin
NUS
$233M
| $6.13M | ﹤0.01% |
108,263
-22,719
| -17% | -$1.29M |
|
2246
Spero Therapeutics
SPRO
$72.4M
| $6.13M | ﹤0.01% |
438,837
+4,049
| +0.9% | +$56.6K |
|
2247
Foster
FSTR
$406M
| $6.11M | ﹤0.01% |
327,655
-3,872
| -1% | -$68K |
|
2248
Smith & Nephew
SNN
$12.5B
| $6.09M | ﹤0.01% |
140,270
+9,115
| +7% | +$384K |
|
2249
Sonic Automotive
SAH
$2.54B
| $6.09M | ﹤0.01% |
136,121
+13,378
| +11% | +$649K |
|
2250
CareDx
CDNA
$2.43B
| $6.09M | ﹤0.01% |
66,492
+10,950
| +20% | +$870K |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.